– Paul GrossmanPh.D. Former SVP Strategy & Corporate Development, Life Technologies/ Venture Partner, Telegraph Hill Partners
We partner with clinical diagnostic start-ups, established diagnostic companies, and investors. We work at every stage—from product concept to clinical use. We leverage our experiences from development through commercial launch to assure your success.
See what a sample of our diverse clients have to say about their experiences working with TynanDx.
Situation: The founders of a small start-up had a promising approach for a new diagnostic platform but lacked commercial experience in the clinical diagnostics market. TynanDx assumed an interim operational role to help them raise their Series A round of financing and help recruit key staff.
“Katherine is that rare talent that understands the full lifecycle of biotech from startup through development, regulatory and commercialization. Her services in the seed round prior to my joining the company were invaluable in helping the founders focus and create a strategic plan that was integral to our successfully raising a $12 Million Series A financing with a lead investor that was introduced to us by Katherine. We continue to utilize her expertise in helping us assess the reimbursement landscape as we plan for commercialization. Further, we continue to benefit from her network of relationships across the diagnostics industry with referral to additional professionals with relevant experience.”
— Steve Tablak
Chairman & CEO, GeneWEAVE
Situation: A large company requested help with an assessment of their current portfolio of businesses and skills in the diagnostics area and a recommendation for future acquisitions to fill in any identified gaps. Longer term, TyanDx provided support to complete those acquisitions and partnerships.
“TynanDx provided a breadth of technical expertise and an in-depth knowledge of the commercial diagnostics market to help us develop and articulate a strategic plan for our technology portfolio that included both internal development projects and in-licensing and acquisition of external technologies. Further, they were able to support us through the acquisition process with comprehensive due diligence and an extensive assessment of the competitive landscape. Their professionalism, knowledge and connections within the diagnostics world were essential to helping us complete this project and receive our Board’s approval for the recommendations.”
— Paul Grossman, Ph.D.
Former SVP Strategy & Corporate Development, Life Technologies/
Venture Partner, Telegraph Hill Partners
Situation: A corporate-backed investment fund sought help identifying companies for potential investment, background on industry trends and due diligence support on prospective investments in precision medicine.
“TynanDx offers us extensive knowledge and expertise in diagnostic technology and market trends in the context of a complex regulatory and reimbursement environment. Over several years they have identified new investment opportunities and have assisted in evaluating multiple deals. We have benefitted from their insights, perspective and industry network.”
— Christopher Earl, Ph.D.
President, Innotrove LLC